CVE-2024-13026

Inadequate Encryption Strength Vulnerability in Roche Algo Edge

CVSS 6.1 MEDIUMEPSS 0.1%CWE-326

Vexday Risk Score

13Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 6.1EPSS 0.1%KEV nãoPoC —Nuclei —Metasploit —Patch referenciado

Lifecycle

17 Jan 2025Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.

CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/S:N/AU:N/R:A/V:D/RE:L/U:Clear

Affected products

Roche Diagnostics · Algorithm Suite

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/Algo%20Edge%20-%20Authentication%20Vulnerability%20-%20Product%20Security%20Advisory.pdf